Loading organizations...
Loading organizations...
Novel medicines using allosteric modulation for enhanced patient care.
Neurosterix has raised $63.0M across 1 funding round.
Neurosterix has raised $63.0M in total across 1 funding round.
Neurosterix has raised $63.0M in total across 1 funding round.
Neurosterix's investors include Fred Callori, Acorn Bioventures.
Neurosterix has raised $63.0M across 1 funding round. Most recently, it raised $63.0M Series A in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 3, 2024 | $63.0M Series A | Fred Callori | Acorn Bioventures |